Overview
- 16 inspections across 16 sites are on record.
- 37 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-11.
At a glance
Inspections
16
Sites
16
Observations
37
Career since
Oct 2024
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Linde Inc. | 11 Jun 2026 | Human Drugs | |
| Oakwood Laboratories LLC | 21 May 2026 | Human Drugs | View 483 → |
| Galaxy Medical Products LLC | 28 Apr 2026 | Human Drugs | On file |
| Baxter Healthcare Corporation | 2 Apr 2026 | Human Drugs | View 483 → |
| Woodbine Products Company Inc. | 13 Feb 2026 | Human Drugs | View 483 → |
Sites inspected
Linde Inc.Ashtabula, United States1 insp.
Oakwood Laboratories LLCSolon, United States1 insp.
Galaxy Medical Products LLCMedina, United States1 insp.
Baxter Healthcare CorporationRound Lake, United States1 insp.
Woodbine Products Company Inc.Medina, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Ramia Brzenjy4 shared
Anna M Spiros2 shared
Logan T Williams2 shared
Andrew J Barrowcliff2 shared
Jeremy T Dautrich1 shared
Paranthaman SenthamaraiKannan1 shared
Robert J Ham1 shared
Elizabeth R Bloom1 shared
Beatrix D Hippe1 shared
Tyler M Peterson1 shared
Full investigator report
Get the verbatim findings behind Supreet K Sran's 37 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site